Revance Therapeutics, Inc.
RVNC
RVNC was delisted on the 5th of February, 2025.
74 hedge funds and large institutions have $463M invested in Revance Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 12 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 25
18% more capital invested
Capital invested by funds: $391M → $463M (+$71.8M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less funds holding
Funds holding: 82 → 74 (-8)
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
91% less call options, than puts
Call options by funds: $16K | Put options by funds: $178K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$2.22M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$2.2M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.79M |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$1.18M |
| 5 |
PC
PointState Capital
New York
|
+$1.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$2.84M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.77M |
| 3 |
IHM
Iguana Healthcare Management
New York
|
-$1.36M |
| 4 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$1.28M |
| 5 |
SCM
Suffolk Capital Management
New York
|
-$982K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
Baird Financial Group
Milwaukee,
Wisconsin
| – | -$1.28M | -94,308 | Closed |
|
|
CAD
77
Craig A. Drill
| – | -$892K | -65,600 | Closed |
|
78
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$699K | -51,400 | Closed |
|
79
Tudor Investment Corp
Stamford,
Connecticut
| – | -$370K | -27,200 | Closed |
|
|
GPP
80
Great Point Partners
Greenwich,
Connecticut
| – | -$295K | -21,665 | Closed |
|
81
AQR Capital Management
Greenwich,
Connecticut
| – | -$164K | -12,073 | Closed |
|
|
FO
82
FT Options
Chicago,
Illinois
| – | -$157K | -11,577 | Closed |
|
83
Teacher Retirement System of Texas
Austin,
Texas
| – | -$37K | -2,753 | Closed |
|
84
Simplex Trading
Chicago,
Illinois
| – | -$10.1K | -694 | Closed |
|
RVNC Hedge Fund Activity: Q3 2016 in Review
74 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Revance Therapeutics, Inc. (RVNC) for Q3 2016, worth a combined $463M — up 18% from $391M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of RVNC and 4 opened new positions — a net loss of 8 holders — while 25 trimmed existing stakes and 30 added.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $2.22M. The largest seller was Bank of New York Mellon, cutting an estimated $2.84M.
- 74 institutional investors held Revance Therapeutics, Inc. (RVNC) as of Q3 2016, down from 82 in Q2 2016.
- Funds reported $463M of Revance Therapeutics, Inc. stock for Q3 2016, up 18% quarter-over-quarter.
- 4 funds opened new Revance Therapeutics, Inc. positions in Q3 2016 and 12 closed out, a net change of -8 holders.
- The largest Revance Therapeutics, Inc. buyer in Q3 2016 was ArrowMark Colorado Holdings, an estimated $2.22M added.
- The largest Revance Therapeutics, Inc. seller in Q3 2016 was Bank of New York Mellon, an estimated $2.84M sold.
Based on aggregated 13F filings for Q3 2016.